Deng P-Y, Kumar A, Cavalli V, and Klyachko VA
Category: 2024
An orally available compound suppresses glucagon hypersecretion and normalizes hyperglycemia in type 1 diabetes (Links to an external site)
Asadi F, Gunawardana SC, Dolle RE, and Piston DW